Lista de obras - Stefano Fiorucci - Dominio Público Uruguay

A magic bullet for mucosal protection...and aspirin is the trigger!

artículo científico publicado en 2003

Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation

artículo científico publicado en 2004

Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone

artículo científico publicado en 2004

Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans

artículo científico publicado en 2004

Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence

artículo científico publicado en 2004

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

artículo científico publicado en 2002

Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis

artículo científico publicado en 2005

Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis

artículo científico publicado en 2012

Dual COX-inhibitors: the answer is NO?

artículo científico publicado en 2005

Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB

artículo científico publicado en 2004

Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin

artículo científico publicado en 2003

Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis

artículo científico publicado en 2003

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study

artículo científico publicado en 2003

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies

artículo científico publicado en 2016

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

artículo científico publicado en 2006

Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs

artículo científico publicado en 2005

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

artículo científico publicado en 2003

Lipoxins in gastric mucosal health and disease

artículo científico publicado en 2005

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors

artículo científico publicado en 2004

NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide

artículo científico publicado en 2002

NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function

artículo científico publicado en 2002

NO-NSAIDs: from inflammatory mediators to clinical readouts

artículo científico publicado en 2006

Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs

artículo científico publicado en 2004

Potential cardioprotective actions of no-releasing aspirin

artículo científico publicado en 2002

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation

artículo científico publicado en 2011

Relative contribution of acetylated cyclooxygenase (COX)‐2 and 5‐lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin ⬇️

artículo científico publicado el 22 de abril de 2003

The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice ⬇️

artículo científico publicado el 8 de octubre de 2010

The bile acid receptor FXR is a modulator of intestinal innate immunity

scientific journal article

Lista de obras de Stefano Fiorucci

A magic bullet for mucosal protection...and aspirin is the trigger!

Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation

Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone

Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans

Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis

Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis

Dual COX-inhibitors: the answer is NO?

Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB

Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin

Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

Lipoxins in gastric mucosal health and disease

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors

NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide

NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function

NO-NSAIDs: from inflammatory mediators to clinical readouts

Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs

Potential cardioprotective actions of no-releasing aspirin

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation

Relative contribution of acetylated cyclooxygenase (COX)‐2 and 5‐lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin ⬇️

The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice ⬇️

The bile acid receptor FXR is a modulator of intestinal innate immunity